1. Home
  2. ONVO

ONVO

Organovo Holdings Inc.

Logo Organovo Holdings Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-24-2024 2:27pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.

Founded: 2007 Country:
N/A
Employees: N/A City: SAN DIEGO
Market Cap: 10.3M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 1.0M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.17 EPS Growth: N/A
52 Week Low/High: $0.89 - $2.24 Next Earning Date: 01-01-0001
Revenue: $242,000 Revenue Growth: -85.83%
Revenue Growth (this year): 20575.68% Revenue Growth (next year): 492.00%

Share on Social Networks: